A randomized phase II study evaluating concurrent or sequential fixed-dose immune therapy in combination with cisplatin and intensity-modulated radiotherapy in intermediate- or high-risk, previously untreated, locally advanced head and neck cancer (LA SCCHN).

被引：0
|
作者：
Clump, David Anthony
Zandberg, Dan Paul
Skinner, Heath Devin
Ohr, James
Fenton, Moon Jung
Normolle, Daniel Paul
Beitler, Jonathan Jay
Bauman, Julie E.
Ferris, Robert L.
机构：
[1] UPMC Hillman Canc Ctr, Pittsburgh, PA USA
[2] Univ Pittsburgh Canc Inst, Seven Fields, PA USA
[3] Univ Pittsburgh, Pittsburgh, PA USA
[4] Emory Univ, Winship Canc Inst, Dept Radiat Oncol, Atlanta, GA USA
[5] Univ Arizona Canc Ctr, Tucson, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6007
引用
收藏
页数：1
相关论文
共 45 条
  • [1] Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinoma
    Yao, Min
    Woods, Charles
    Lavertu, Pierre
    Fu, Pingfu
    Gibson, Michael
    Rezaee, Rod
    Zender, Chad
    Wasman, Jay
    Sharma, Neelesh
    Machtay, Mitchell
    Savvides, Panayiotis
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E1770 - E1776
  • [2] Intermediate- and High-Risk Prostate Cancer: A Plea for High-Dose, High-Precision Intensity-Modulated Radiotherapy With a Modulated Duration of Androgen Deprivation Therapy
    Bolla, Michel
    EUROPEAN UROLOGY, 2011, 60 (06) : 1140 - 1141
  • [3] FEASIBILITY STUDY OF MODERATELY ACCELERATED INTENSITY-MODULATED RADIOTHERAPY PLUS CONCURRENT WEEKLY CISPLATIN AFTER INDUCTION CHEMOTHERAPY IN LOCALLY ADVANCED HEAD-AND NECK CANCER
    Morganti, Alessio G.
    Mignogna, Samantha
    Deodato, Francesco
    Massaccesi, Mariangela
    Cilla, Savino
    Calista, Franco
    Serafini, Giovanni
    Digesu, Cinzia
    Macchia, Gabriella
    Picardi, Vincenzo
    Caravatta, Luciana
    Di Lullo, Liberato
    Giglio, Gianfranco
    Sallustio, Giuseppina
    Piermattei, Angelo
    Cellini, Numa
    Valentini, Vincenzo
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (04): : 1073 - 1080
  • [4] A phase II trial of postoperative radiotherapy (RT), cisplatin, and panitumumab in patients with high-risk, resected locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Ferris, R. L.
    Kotsakis, A. P.
    Heron, D. E.
    Kim, S.
    Duvvuri, U.
    Kubicek, G. J.
    Grandis, J. R.
    Johnson, J. T.
    Argiris, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial
    Tao, Yungan
    Auperin, Anne
    Blanchard, Pierre
    Alfonsi, Marc
    Sun, Xu-Shan
    Rives, Michel
    Pointreau, Yoann
    Castelli, Joel
    Graff, Pierre
    Kam, Stephanie Wong Hee
    Thariat, Juliette
    Veresezan, Ovidiu
    Heymann, Steve
    Renard-Oldrini, Sophie
    Lafond, Cedrik
    Cornely, Alexandre
    Casiraghi, Odile
    Boisselier, Pierre
    Lapeyre, Michel
    Biau, Julian
    Bourhis, Jean
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : 18 - 25
  • [6] Concurrent definitive chemoradiation incorporating intensity-modulated radiotherapy followed by adjuvant chemotherapy in high risk locally advanced cervical squamous cancer: a phase II study
    Zhang, Gong-yi
    Zhang, Rong
    Bai, Ping
    Li, Shu-min
    Zhang, Yuan-yuan
    Chen, Yi-ran
    Huang, Man-ni
    Wu, Ling-ying
    BMC CANCER, 2022, 22 (01)
  • [7] Concurrent definitive chemoradiation incorporating intensity-modulated radiotherapy followed by adjuvant chemotherapy in high risk locally advanced cervical squamous cancer: a phase II study
    Gong-yi Zhang
    Rong Zhang
    Ping Bai
    Shu-min Li
    Yuan-yuan Zhang
    Yi-ran Chen
    Man-ni Huang
    Ling-ying Wu
    BMC Cancer, 22
  • [8] Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional chemo-radiotherapy for locally advanced (LA) head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial
    Tao, Y.
    Auperin, A.
    Blanchard, P.
    Alfonsi, M.
    Sun, X-S.
    Rives, M.
    Pointreau, Y.
    Castelli, J.
    Graff, P.
    Kam, S. Wong Hee
    Thariat, J.
    Veresezan, O.
    Cornely, A.
    Casiraghi, O.
    Lapeyre, M.
    Bourhis, J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [9] Phase 1 dose-finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer
    Gulati, Shuchi
    Desai, Janki
    Palackdharry, Sarah M.
    Morris, John C.
    Zhu, Zheng
    Jandarov, Roman
    Riaz, Muhammad K.
    Takiar, Vinita
    Mierzwa, Michelle
    Gutkind, J. Silvio
    Molinolo, Alfredo
    Desai, Pankaj B.
    Sadraei, Nooshin Hashemi
    Wise-Draper, Trisha M.
    CANCER, 2020, 126 (02) : 354 - 362
  • [10] High-dose (60 Gy) intensity-modulated radiotherapy with concurrent weekly cisplatin followed by intracavitary radiation in locally advanced cervical cancer: A phase II prospective clinical trial
    Lee, Hyo Chun
    Jeong, Jae Won
    Lee, Joo Hwan
    Kim, Sung Hwan
    Park, Dong Chun
    Yoon, Joo Hee
    Kim, Sang Il
    Lee, Jong Hoon
    GYNECOLOGIC ONCOLOGY, 2023, 177 : 142 - 149
12345